AU4531099A - Pharmaceutical compositions containing low-melting waxes - Google Patents

Pharmaceutical compositions containing low-melting waxes

Info

Publication number
AU4531099A
AU4531099A AU45310/99A AU4531099A AU4531099A AU 4531099 A AU4531099 A AU 4531099A AU 45310/99 A AU45310/99 A AU 45310/99A AU 4531099 A AU4531099 A AU 4531099A AU 4531099 A AU4531099 A AU 4531099A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
compositions containing
containing low
melting waxes
waxes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45310/99A
Inventor
Meir Bialer
Amnon Sintov
Andrew Volosov
Boris Yagen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of AU4531099A publication Critical patent/AU4531099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
AU45310/99A 1998-07-07 1999-07-06 Pharmaceutical compositions containing low-melting waxes Abandoned AU4531099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL125244 1998-07-07
IL12524498A IL125244A (en) 1998-07-07 1998-07-07 Pharmaceutical compositions containing low-melting waxes
PCT/IL1999/000365 WO2000001416A1 (en) 1998-07-07 1999-07-06 Pharmaceutical compositions containing low-melting waxes

Publications (1)

Publication Number Publication Date
AU4531099A true AU4531099A (en) 2000-01-24

Family

ID=11071714

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45310/99A Abandoned AU4531099A (en) 1998-07-07 1999-07-06 Pharmaceutical compositions containing low-melting waxes

Country Status (4)

Country Link
EP (1) EP1094842A1 (en)
AU (1) AU4531099A (en)
IL (1) IL125244A (en)
WO (1) WO2000001416A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052706B2 (en) 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
WO2004014391A1 (en) * 2002-08-06 2004-02-19 Novartis Ag Use of carboxamides for the treatment of tinnitus
BR0318167A (en) * 2003-03-04 2006-02-21 Nostrum Pharmaceuticals Inc controlled release formulation containing a hydrophobic material as the controlled release agent
ITMI20032399A1 (en) 2003-12-09 2005-06-10 Zambon Spa PHARMACEUTICAL COMPOSITION CONTAINING GABAPENTIN.
AR048672A1 (en) * 2004-03-22 2006-05-17 Novartis Ag DISINTEGRATION TABLETS THAT INCLUDE LICARBAZEPINA
AR048318A1 (en) * 2004-03-22 2006-04-19 Novartis Ag ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
US20060275367A1 (en) * 2005-04-25 2006-12-07 Shubha Chungi Extended release formulations
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
BRPI0910382B1 (en) 2008-07-18 2021-07-06 Biomod Concepts Inc ARTICLE TO APPLY AN ACTIVE INGREDIENT, APPLICATION VEHICLE FOR TRANSFER OF MICROPARTICLES TO A SUBSTRATE, MICROPARTICLE TO RELEASE AN ACTIVE INGREDIENT AND METHOD TO RELEASE AN ACTIVE INGREDIENT
CN107921073B (en) * 2015-06-01 2022-10-18 塞诺生物科学股份有限公司 Methods and compositions for regulating gut microbiota and managing weight
US10342886B2 (en) 2016-01-26 2019-07-09 S.C. Johnson & Son, Inc. Extruded wax melt and method of producing same
US10010638B2 (en) 2016-06-14 2018-07-03 S. C. Johnson & Son, Inc. Wax melt with filler

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
ZA898331B (en) * 1988-11-22 1990-07-25 Hoffmann La Roche Pharmaceutical compositions
JP3418274B2 (en) * 1995-06-05 2003-06-16 日本化薬株式会社 Tablets with good oral feel

Also Published As

Publication number Publication date
IL125244A0 (en) 1999-03-12
WO2000001416A1 (en) 2000-01-13
IL125244A (en) 2002-12-01
EP1094842A1 (en) 2001-05-02

Similar Documents

Publication Publication Date Title
AU4413299A (en) Stabilized pharmaceutical compositions
AU4969699A (en) Aerosol antimicrobial compositions
AU5982999A (en) Antiperspirant compositions
AU3949999A (en) Perfume compositions
AU4762797A (en) Pharmaceutical compositions
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
AU2967597A (en) Pharmaceutical compositions
AU6740298A (en) Pharmaceutical composition
AU3556400A (en) Pharmaceutical compositions
AU1574900A (en) Pharmaceutical compositions containing insulin
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU4531099A (en) Pharmaceutical compositions containing low-melting waxes
AU3976800A (en) Antiperspirant compositions
AU6370299A (en) Pharmaceutical compositions containing tetrahydroisoquinoline compounds
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU3907697A (en) Decolorizing compositions
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
AU6460400A (en) Pharmaceutical compositions
AUPN933396A0 (en) Non-aqueuos oral-drench compositions containing avermectin compounds
AU6256298A (en) Cosmetic compositions
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU9343098A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase